Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.

Monroe Carell Jr. Children’s Hospital at Vanderbilt is set to begin a phase 2/3 clinical trial to study the safety and efficacy of the Moderna COVID-19 vaccine in children.

Monroe Carell Jr. Children’s Hospital at Vanderbilt’s pediatric primary care clinics have earned the National Committee for Quality Assurance’s (NCQA) Patient-Centered Medical Home Recognition for demonstrating evidence-based practices that ensure excellence and quality of care for all patients and families.

Statewide stay-at-home orders put in place as Tennessee fought to control the spread of coronavirus last March were associated with a 14% lower rate of preterm birth, according to a research letter published today in JAMA Pediatrics.

The U.S. Centers for Disease Control and Prevention (CDC) has awarded Vanderbilt University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19.

The James Puckette Carter Scholars Program, the result of a partnership between Meharry Medical College (MMC), Vanderbilt University Medical Center and the Burroughs Wellcome Fund (BWF), intended to increase the number of physicians who attended Historically Black Colleges and Universities (HBCUs) in health care, is expanding to double its enrollment capacity.

Monroe Carell Jr. Children’s Hospital at Vanderbilt patient Lochlin Morris was named Champ of the Game at the Nashville Predators’ Hockey Fights Cancer game on Saturday, March 6. Beginning last season, each home game features a Children’s Hospital patient on the jumbotron as a Vanderbilt Health Champ of the Game.